1. Home
  2. SPRB vs PSHG Comparison

SPRB vs PSHG Comparison

Compare SPRB & PSHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRB
  • PSHG
  • Stock Information
  • Founded
  • SPRB 2014
  • PSHG 2010
  • Country
  • SPRB United States
  • PSHG Greece
  • Employees
  • SPRB N/A
  • PSHG N/A
  • Industry
  • SPRB Medicinal Chemicals and Botanical Products
  • PSHG Marine Transportation
  • Sector
  • SPRB Health Care
  • PSHG Consumer Discretionary
  • Exchange
  • SPRB Nasdaq
  • PSHG Nasdaq
  • Market Cap
  • SPRB 22.8M
  • PSHG 24.2M
  • IPO Year
  • SPRB 2020
  • PSHG N/A
  • Fundamental
  • Price
  • SPRB $0.52
  • PSHG $1.96
  • Analyst Decision
  • SPRB Hold
  • PSHG Strong Buy
  • Analyst Count
  • SPRB 7
  • PSHG 1
  • Target Price
  • SPRB $2.50
  • PSHG $6.50
  • AVG Volume (30 Days)
  • SPRB 400.8K
  • PSHG 69.3K
  • Earning Date
  • SPRB 11-11-2024
  • PSHG 11-07-2024
  • Dividend Yield
  • SPRB N/A
  • PSHG N/A
  • EPS Growth
  • SPRB N/A
  • PSHG N/A
  • EPS
  • SPRB N/A
  • PSHG 1.51
  • Revenue
  • SPRB $7,101,000.00
  • PSHG $89,608,000.00
  • Revenue This Year
  • SPRB N/A
  • PSHG N/A
  • Revenue Next Year
  • SPRB N/A
  • PSHG $2.66
  • P/E Ratio
  • SPRB N/A
  • PSHG $1.30
  • Revenue Growth
  • SPRB N/A
  • PSHG N/A
  • 52 Week Low
  • SPRB $0.41
  • PSHG $1.70
  • 52 Week High
  • SPRB $5.95
  • PSHG $2.58
  • Technical
  • Relative Strength Index (RSI)
  • SPRB 47.26
  • PSHG 45.21
  • Support Level
  • SPRB $0.51
  • PSHG $1.92
  • Resistance Level
  • SPRB $0.56
  • PSHG $2.04
  • Average True Range (ATR)
  • SPRB 0.03
  • PSHG 0.08
  • MACD
  • SPRB -0.01
  • PSHG -0.01
  • Stochastic Oscillator
  • SPRB 16.61
  • PSHG 4.55

About SPRB Spruce Biosciences Inc.

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

About PSHG Performance Shipping Inc.

Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates eight Aframax tanker vessels.

Share on Social Networks: